Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-12 Sale | 2022-09-14 4:24 pm | SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 153,897 | $31.96 | $4,919,148 | 5,599,842 (Indirect) | View |
| 2022-08-08 Sale | 2022-08-10 4:22 pm | SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 274,568 | $38.11 | $10,464,363 | 5,753,739 (Indirect) | View |
| 2021-10-20 Sale | 2021-10-20 7:14 pm | SpringWorks Therapeutics Inc. | SWTX | Islam Saqib CEO | 10,083 | $58.67 | $591,527 | 779,218 (Direct) | View |
| 2021-10-18 Sale | 2021-10-19 7:27 pm | SpringWorks Therapeutics Inc. | SWTX | Islam Saqib CEO | 52,417 | $58.65 | $3,074,378 | 769,135 (Direct) | View |
| 2021-10-13 Sale | 2021-10-13 8:24 pm | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $55.97 | $559,675 | 251,807 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-07-18 Tax Withholding | 2022-07-20 6:02 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 1,551 | $28.47 | 193,076 (Direct) | View |
| 2022-07-18 Tax Withholding | 2022-07-20 6:02 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development | 3,103 | $28.47 | 49,584 (Direct) | View |
| 2022-07-14 Option Award | 2022-07-15 06:07 am | N/A 2032-07-14 | SpringWorks Therapeutics Inc. | SWTX | ALBAN CARLOS Director | 40,218 | $0 | 40,218 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 5:30 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 6,092 | $0 | 194,627 (Direct) | View |
| 2022-06-01 Tax Withholding | 2022-07-05 5:29 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development | 2,672 | $19.61 | 52,687 (Direct) | View |
| 2022-06-01 Option Award | 2022-07-05 5:29 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development | 12,185 | $0 | 52,687 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 6:23 pm | N/A 2032-05-19 | SpringWorks Therapeutics Inc. | SWTX | Schwartz Jeffrey Lawrence Director | 20,136 | $0 | 4,852,549 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 5:44 pm | N/A 2032-05-19 | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 20,136 | $0 | 6,333,277 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 5:43 pm | N/A 2032-05-19 | SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director | 20,136 | $0 | 312,519 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 5:41 pm | N/A 2032-05-19 | SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director | 20,136 | $0 | 21,242 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 5:40 pm | N/A 2032-05-19 | SpringWorks Therapeutics Inc. | SWTX | Hambleton Julie Director | 20,136 | $0 | 21,242 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 5:39 pm | N/A 2032-05-19 | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director | 20,136 | $0 | 21,242 (Direct) | View |
| 2022-01-07(A) Tax Withholding | 2022-01-14 4:59 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Nofi Michael CAO | 414 | $56.06 | 8,334 (Direct) | View |
| 2022-01-07(A) Tax Withholding | 2022-01-14 4:59 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer | 631 | $56.06 | 21,667 (Direct) | View |
| 2022-01-07(A) Tax Withholding | 2022-01-14 4:58 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel & Secretary | 966 | $56.06 | 19,096 (Direct) | View |
| 2022-01-07(A) Tax Withholding | 2022-01-14 4:58 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Perier Francis I Jr CFO | 1,307 | $56.06 | 27,502 (Direct) | View |
| 2022-01-07(A) Tax Withholding | 2022-01-14 4:58 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 1,181 | $56.06 | 188,535 (Direct) | View |
| 2022-01-07(A) Tax Withholding | 2022-01-14 4:58 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer | 1,852 | $56.06 | 325,813 (Direct) | View |
| 2022-01-07(A) Tax Withholding | 2022-01-14 4:57 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Islam Saqib CEO | 3,996 | $56.06 | 853,592 (Direct) | View |
| 2022-01-07 Tax Withholding | 2022-01-11 4:04 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel & Secretary | 1,323 | $56.06 | 18,739 (Direct) | View |
| 2022-01-07 Tax Withholding | 2022-01-11 4:04 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer | 842 | $56.06 | 21,456 (Direct) | View |
| 2022-01-07 Tax Withholding | 2022-01-11 4:04 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Francis Perier I Jr CFO | 1,846 | $56.06 | 26,963 (Direct) | View |
| 2022-01-07 Tax Withholding | 2022-01-11 4:03 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Nofi Michael CAO | 567 | $56.06 | 8,181 (Direct) | View |
| 2022-01-07 Tax Withholding | 2022-01-11 4:03 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 1,772 | $56.06 | 187,944 (Direct) | View |
| 2022-01-07 Tax Withholding | 2022-01-11 4:02 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Islam Saqib CEO | 5,893 | $56.06 | 851,695 (Direct) | View |
| 2022-01-07 Tax Withholding | 2022-01-11 4:02 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer | 2,531 | $56.06 | 325,134 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 4:31 pm | N/A 2032-01-06 | SpringWorks Therapeutics Inc. | SWTX | Islam Saqib CEO | 322,628 | $0 | 1,101,846 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 4:27 pm | N/A 2032-01-06 | SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer | 107,544 | $0 | 409,085 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 4:26 pm | N/A 2032-01-06 | SpringWorks Therapeutics Inc. | SWTX | Francis Perier I Jr CFO | 77,431 | $0 | 87,431 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 4:25 pm | N/A 2032-01-06 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 91,412 | $0 | 258,923 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 4:25 pm | N/A 2032-01-06 | SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel & Secretary | 53,772 | $0 | 60,772 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 4:24 pm | N/A 2032-01-06 | SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer | 53,772 | $0 | 63,008 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 4:23 pm | N/A 2032-01-06 | SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development | 64,526 | $0 | 92,026 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 4:23 pm | N/A 2032-01-06 | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 53,772 | $0 | 66,272 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 4:22 pm | N/A 2032-01-06 | SpringWorks Therapeutics Inc. | SWTX | Nofi Michael CAO | 23,661 | $0 | 26,661 (Direct) | View |
| 2021-10-13 Exercise | 2021-10-13 8:24 pm | N/A 2029-04-22 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $0 | 251,807 (Direct) | View |
| 2021-10-13 Exercise | 2021-10-13 8:24 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $2.3 | 251,807 (Direct) | View |